2020
DOI: 10.1111/cmi.13241
|View full text |Cite
|
Sign up to set email alerts
|

TypeVIsecretion system effector proteins: Effective weapons for bacterial competitiveness

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
101
0

Year Published

2020
2020
2023
2023

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 114 publications
(112 citation statements)
references
References 58 publications
0
101
0
Order By: Relevance
“…SsdAI is an exclusively a-helical protein that shares a large (~1300 Å 2 ) interface with SsdA. As is often observed in toxin-immunity co-crystal structures, this interface effectively demarcates the active site of SsdA ( Figure 6A) (13). Much of the SsdA-interacting surface of SsdAI is composed of a protrusion that includes an extended loop and two short helical segments that project residues into the active site cavity of SsdA ( Figure 6F).…”
Section: The Ssda Structure Specifies a New Group Of Bacterial Deaminmentioning
confidence: 82%
See 1 more Smart Citation
“…SsdAI is an exclusively a-helical protein that shares a large (~1300 Å 2 ) interface with SsdA. As is often observed in toxin-immunity co-crystal structures, this interface effectively demarcates the active site of SsdA ( Figure 6A) (13). Much of the SsdA-interacting surface of SsdAI is composed of a protrusion that includes an extended loop and two short helical segments that project residues into the active site cavity of SsdA ( Figure 6F).…”
Section: The Ssda Structure Specifies a New Group Of Bacterial Deaminmentioning
confidence: 82%
“…Beyond these outcomes that are detrimental to recipient cells, there are also scenarios in which toxin delivery could provide a transient benefit. Within populations of toxin producing strains, self-intoxication is prevented through the production of specific immunity determinants that neutralize individual toxins (13). Toxins inactivated by immunity proteins in this manner are generally assumed to have no or little impact.…”
Section: Introductionmentioning
confidence: 99%
“…T6SS is a versatile machinery playing roles in both pathogenesis and interbacterial competition by translocating T6SS effectors. T6SS effectors are loaded into the inner tube or associate with the spike trimer during T6SS assembly (Silverman et al, 2013;Flaugnatti et al, 2016;Hernandez et al, 2020). Contraction of the sheath propels the inner tube/spike, which allows perforation of the target cell membrane, delivering effectors into the cytosol of target cells (Journet and Cascales, 2016).…”
Section: Discussionmentioning
confidence: 99%
“…Besides the core apparatus protein, EvpP (T6SS effector protein), EvpC (a homolog of Hcp), and EvpI (a homolog of VgrG) are three secreted proteins encoded inside the T6SS gene cluster (Zheng and Leung, 2007). T6SS is a contractile injection apparatus that translocates a tail tube and a spike loaded with various effectors directly into eukaryotic or prokaryotic target cells (Silverman et al, 2013;Flaugnatti et al, 2016;Hernandez et al, 2020;Wettstadt and Filloux, 2020). The T6SS spike punctures the bacterial cell envelope allowing the transport of effectors, and it consists of a torch-like VgrG trimer (encoded by evpI in E. piscicida) on which sits a PAAR protein sharpening the VgrG tip (encoded by evpJ in E. piscicida), and VgrG itself sits on the Hcp tube (encoded by evpC in E. piscicida).…”
Section: Introductionmentioning
confidence: 99%
“…Most T6SS effectors have anti‐bacterial activity and have been proven quite efficient against other gram‐negative bacteria although anti‐eukaryotic effectors against animal and fungi cells have been also described (Allsopp et al ., 2020). Antimicrobial effectors target nucleic acids (nucleases) or other essential cytoplasmic elements (ADP‐ribosyl transferases (Tre1), glycohydrolases (Tne), and (p)ppApp synthases (Tas1) or disrupt the cell wall (amidases, muramidases) or the cytoplasmic membrane (lipases, pore‐forming bacteriocins) (Hernandez et al ., 2020). The arsenal of T6SS effectors has continued to grow since the first identified T6 effector (Hood et al ., 2010) and nowadays about 10 to 20 has been described for Pseudomonas aeruginosa and Vibrio cholerae .…”
Section: Type VI Secretion Systemmentioning
confidence: 99%